These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 12922150)
1. Controlled release by biodegradable hydrogels enhances the ectopic bone formation of bone morphogenetic protein. Yamamoto M; Takahashi Y; Tabata Y Biomaterials; 2003 Nov; 24(24):4375-83. PubMed ID: 12922150 [TBL] [Abstract][Full Text] [Related]
2. Ectopic bone formation induced by biodegradable hydrogels incorporating bone morphogenetic protein. Yamamoto M; Tabata Y; Ikada Y J Biomater Sci Polym Ed; 1998; 9(5):439-58. PubMed ID: 9648026 [TBL] [Abstract][Full Text] [Related]
3. Skull bone regeneration in nonhuman primates by controlled release of bone morphogenetic protein-2 from a biodegradable hydrogel. Takahashi Y; Yamamoto M; Yamada K; Kawakami O; Tabata Y Tissue Eng; 2007 Feb; 13(2):293-300. PubMed ID: 17504062 [TBL] [Abstract][Full Text] [Related]
4. Enhanced bone regeneration at a segmental bone defect by controlled release of bone morphogenetic protein-2 from a biodegradable hydrogel. Yamamoto M; Takahashi Y; Tabata Y Tissue Eng; 2006 May; 12(5):1305-11. PubMed ID: 16771643 [TBL] [Abstract][Full Text] [Related]
5. Enhanced osteoinduction by controlled release of bone morphogenetic protein-2 from biodegradable sponge composed of gelatin and beta-tricalcium phosphate. Takahashi Y; Yamamoto M; Tabata Y Biomaterials; 2005 Aug; 26(23):4856-65. PubMed ID: 15763265 [TBL] [Abstract][Full Text] [Related]
6. Controlled release of bone morphogenetic protein-2 enhances recruitment of osteogenic progenitor cells for de novo generation of bone tissue. Kimura Y; Miyazaki N; Hayashi N; Otsuru S; Tamai K; Kaneda Y; Tabata Y Tissue Eng Part A; 2010 Apr; 16(4):1263-70. PubMed ID: 19886805 [TBL] [Abstract][Full Text] [Related]
7. Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineering. Kempen DH; Lu L; Hefferan TE; Creemers LB; Maran A; Classic KL; Dhert WJ; Yaszemski MJ Biomaterials; 2008 Aug; 29(22):3245-52. PubMed ID: 18472153 [TBL] [Abstract][Full Text] [Related]
8. Bone regeneration by transforming growth factor beta1 released from a biodegradable hydrogel. Yamamoto M; Tabata Y; Hong L; Miyamoto S; Hashimoto N; Ikada Y J Control Release; 2000 Feb; 64(1-3):133-42. PubMed ID: 10640652 [TBL] [Abstract][Full Text] [Related]
9. An analysis of bone regeneration at a segmental bone defect by controlled release of bone morphogenetic protein 2 from a biodegradable sponge composed of gelatin and β-tricalcium phosphate. Fujita N; Matsushita T; Ishida K; Sasaki K; Kubo S; Matsumoto T; Kurosaka M; Tabata Y; Kuroda R J Tissue Eng Regen Med; 2012 Apr; 6(4):291-8. PubMed ID: 21706776 [TBL] [Abstract][Full Text] [Related]
10. Bovine BMP osteoinductive potential enhanced by functionalized dextran-derived hydrogels. Maire M; Chaubet F; Mary P; Blanchat C; Meunier A; Logeart-Avramoglou D Biomaterials; 2005 Aug; 26(24):5085-92. PubMed ID: 15769544 [TBL] [Abstract][Full Text] [Related]
11. Effects of carrier release kinetics on bone morphogenetic protein-2-induced periodontal regeneration in vivo. Talwar R; Di Silvio L; Hughes FJ; King GN J Clin Periodontol; 2001 Apr; 28(4):340-7. PubMed ID: 11314890 [TBL] [Abstract][Full Text] [Related]
13. Sustained release of rhBMP-2 from microporous tricalciumphosphate using hydrogels as a carrier. Kissling S; Seidenstuecker M; Pilz IH; Suedkamp NP; Mayr HO; Bernstein A BMC Biotechnol; 2016 May; 16(1):44. PubMed ID: 27206764 [TBL] [Abstract][Full Text] [Related]
14. Vascularization effect of basic fibroblast growth factor released from gelatin hydrogels with different biodegradabilities. Tabata Y; Ikada Y Biomaterials; 1999 Nov; 20(22):2169-75. PubMed ID: 10555085 [TBL] [Abstract][Full Text] [Related]
15. Bone morphogenetic protein-2 in biodegradable gelatin and β-tricalcium phosphate sponges enhances the in vivo bone-forming capability of bone marrow mesenchymal stem cells. Tadokoro M; Matsushima A; Kotobuki N; Hirose M; Kimura Y; Tabata Y; Hattori K; Ohgushi H J Tissue Eng Regen Med; 2012 Apr; 6(4):253-60. PubMed ID: 21548136 [TBL] [Abstract][Full Text] [Related]
16. The influence of collagen and hyaluronan matrices on the delivery and bioactivity of bone morphogenetic protein-2 and ectopic bone formation. Bhakta G; Lim ZX; Rai B; Lin T; Hui JH; Prestwich GD; van Wijnen AJ; Nurcombe V; Cool SM Acta Biomater; 2013 Nov; 9(11):9098-106. PubMed ID: 23871940 [TBL] [Abstract][Full Text] [Related]
17. Novel glycidyl methacrylated dextran (Dex-GMA)/gelatin hydrogel scaffolds containing microspheres loaded with bone morphogenetic proteins: formulation and characteristics. Chen FM; Zhao YM; Sun HH; Jin T; Wang QT; Zhou W; Wu ZF; Jin Y J Control Release; 2007 Mar; 118(1):65-77. PubMed ID: 17250921 [TBL] [Abstract][Full Text] [Related]
18. Preparation and biological characteristics of recombinant human bone morphogenetic protein-2-loaded dextran-co-gelatin hydrogel microspheres, in vitro and in vivo studies. Chen F; Wu Z; Wang Q; Wu H; Zhang Y; Nie X; Jin Y Pharmacology; 2005 Nov; 75(3):133-44. PubMed ID: 16155372 [TBL] [Abstract][Full Text] [Related]
19. Controlled release of growth factors based on biodegradation of gelatin hydrogel. Yamamoto M; Ikada Y; Tabata Y J Biomater Sci Polym Ed; 2001; 12(1):77-88. PubMed ID: 11334191 [TBL] [Abstract][Full Text] [Related]
20. Controlled release of plasmid DNA from cationized gelatin hydrogels based on hydrogel degradation. Fukunaka Y; Iwanaga K; Morimoto K; Kakemi M; Tabata Y J Control Release; 2002 Apr; 80(1-3):333-43. PubMed ID: 11943409 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]